GWMIA
AIM

Global Wealth Management Investment Advisory’s AIM ImmunoTech AIM Stock Holding History

Global Wealth Management Investment Advisory’s Portfolio AIM Stock Details AIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-6
Closed -$1K – 512
2021
Q1 		$1K Buy
+6
New +$1.35K ﹤0.01% 453

Other funds holding AIM

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Global Wealth Management Investment Advisory's AIM Position: Q2 2021 in Review

Global Wealth Management Investment Advisory sold out of AIM ImmunoTech (AIM) in Q2 2021, closing a stake of 6 shares — an estimated $1K sold.

Global Wealth Management Investment Advisory first reported a position in AIM in Q1 2021 and held it in 1 quarter. The position peaked at $1K in Q1 2021. 35 funds tracked by Wall St. Rank hold AIM as of Q2 2021.

  • Global Wealth Management Investment Advisory reported no remaining AIM ImmunoTech position as of Q2 2021 after selling out during the quarter.
  • Global Wealth Management Investment Advisory sold 6 AIM ImmunoTech shares in Q2 2021, an estimated $1K.
  • Global Wealth Management Investment Advisory first reported a position in AIM ImmunoTech in Q1 2021 and held it in 1 quarter.
  • Global Wealth Management Investment Advisory's AIM ImmunoTech position peaked at $1K in Q1 2021.
  • 35 funds tracked by Wall St. Rank held AIM ImmunoTech as of Q2 2021.

Based on Global Wealth Management Investment Advisory's 13F filing for Q2 2021, filed 11 Aug 2021.